ASCO 2026: A New Way to Track HPV Cancer - Top-Institutions - MDSpire

ASCO 2026: A New Way to Track HPV Cancer

A head-to-head comparison of ctDNA and ctHPV DNA reveals complementary insights into treatment response and recurrence risk

  • By

  • Jessica Allerton

  • June 18, 2026

  • 3 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    American Society of Clinical Oncology (ASCO)
    American Society of Clinical Oncology (ASCO)

    Alexandria, Virginia

    Key Differentiators

    • Oncology

  • #2

    University of Chicago
    University of Chicago

    Chicago, Illinois

    Key Differentiators

    • Oncology

  • #3

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Oncology

  • #4

    City of Hope
    City of Hope

    Duarte, California

    Key Differentiators

    • Oncology

  • #5

    McGill University
    McGill University

    Montreal, Quebec

    Key Differentiators

    • Oncology

Original Source(s)

ASCO 2026: A New Way to Track HPV Cancer

  • by Jessica Allerton

  • June 18, 2026

Related Content

Case Report: Recurrent uterine inflammatory myofibroblastic tumor harboring IGFBP5-ALK fusion with sustained response to iruplinalkib

In Memoriam: Richard Scolyer

Remembering the celebrated Australian pathologist who inspired new research into brain cancer treatment

Case Report: KIF5B-ALK–rearranged renal cell carcinoma